Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 4 | 2022 | 266 | 2.210 |
Why?
|
| Stroke | 6 | 2022 | 1059 | 2.090 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2018 | 103 | 1.050 |
Why?
|
| Cerebral Hemorrhage | 4 | 2021 | 157 | 0.990 |
Why?
|
| Hematoma | 3 | 2020 | 85 | 0.880 |
Why?
|
| Anticoagulants | 2 | 2021 | 601 | 0.820 |
Why?
|
| Brain Edema | 2 | 2021 | 66 | 0.790 |
Why?
|
| Space Flight | 3 | 2020 | 176 | 0.720 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2020 | 70 | 0.710 |
Why?
|
| Diuretics, Osmotic | 1 | 2021 | 4 | 0.690 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 737 | 0.680 |
Why?
|
| Mannitol | 1 | 2021 | 40 | 0.680 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2021 | 20 | 0.680 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 267 | 0.680 |
Why?
|
| Glasgow Coma Scale | 2 | 2020 | 200 | 0.610 |
Why?
|
| Common Data Elements | 1 | 2019 | 6 | 0.600 |
Why?
|
| Neurology | 1 | 2021 | 116 | 0.590 |
Why?
|
| Aneurysm, Ruptured | 1 | 2019 | 36 | 0.580 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 182 | 0.500 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 191 | 0.500 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 298 | 0.500 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 209 | 0.480 |
Why?
|
| Secondary Prevention | 1 | 2016 | 216 | 0.450 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 890 | 0.400 |
Why?
|
| Thrombectomy | 2 | 2021 | 117 | 0.310 |
Why?
|
| Adaptation, Physiological | 3 | 2020 | 258 | 0.310 |
Why?
|
| Safe Sex | 1 | 2009 | 16 | 0.310 |
Why?
|
| Condoms | 1 | 2009 | 49 | 0.300 |
Why?
|
| Sexual Partners | 1 | 2009 | 79 | 0.290 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2009 | 94 | 0.280 |
Why?
|
| Object Attachment | 1 | 2009 | 64 | 0.280 |
Why?
|
| History, 20th Century | 2 | 2021 | 363 | 0.280 |
Why?
|
| Intracranial Pressure | 2 | 2019 | 214 | 0.240 |
Why?
|
| Blood Pressure | 3 | 2020 | 1344 | 0.240 |
Why?
|
| Hospitals, Rural | 1 | 2025 | 16 | 0.230 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2025 | 33 | 0.230 |
Why?
|
| Hospitals, Urban | 1 | 2025 | 97 | 0.220 |
Why?
|
| Humans | 19 | 2025 | 130534 | 0.210 |
Why?
|
| Middle Aged | 9 | 2025 | 28408 | 0.190 |
Why?
|
| Checklist | 1 | 2022 | 97 | 0.180 |
Why?
|
| History, 18th Century | 1 | 2021 | 68 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12846 | 0.170 |
Why?
|
| History, 19th Century | 1 | 2021 | 109 | 0.170 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 18 | 0.160 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 208 | 0.150 |
Why?
|
| Risk Factors | 5 | 2021 | 11013 | 0.150 |
Why?
|
| Vasoconstriction | 1 | 2020 | 94 | 0.150 |
Why?
|
| Hospital Mortality | 2 | 2025 | 1059 | 0.150 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2019 | 3 | 0.150 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2019 | 13 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2021 | 3685 | 0.150 |
Why?
|
| Brain | 3 | 2020 | 3167 | 0.150 |
Why?
|
| Hyponatremia | 1 | 2020 | 73 | 0.150 |
Why?
|
| Vision, Ocular | 1 | 2019 | 117 | 0.140 |
Why?
|
| Sodium | 1 | 2020 | 280 | 0.140 |
Why?
|
| Astronauts | 1 | 2019 | 81 | 0.140 |
Why?
|
| Magnesium | 1 | 2019 | 114 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 88 | 0.140 |
Why?
|
| Texas | 3 | 2020 | 3663 | 0.140 |
Why?
|
| Aged | 7 | 2025 | 20885 | 0.140 |
Why?
|
| Cost Savings | 1 | 2018 | 79 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2018 | 234 | 0.130 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 59 | 0.130 |
Why?
|
| Hospitalization | 2 | 2025 | 1942 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17634 | 0.130 |
Why?
|
| Neurophysiological Monitoring | 1 | 2018 | 41 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 723 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 715 | 0.120 |
Why?
|
| Prognosis | 3 | 2020 | 4866 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1263 | 0.120 |
Why?
|
| Warfarin | 1 | 2016 | 121 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 111 | 0.110 |
Why?
|
| Stents | 1 | 2021 | 788 | 0.110 |
Why?
|
| Intracranial Hypertension | 1 | 2015 | 134 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 554 | 0.100 |
Why?
|
| Male | 9 | 2025 | 64613 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 461 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2019 | 561 | 0.100 |
Why?
|
| Female | 9 | 2025 | 70545 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 75 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 393 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2012 | 106 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2018 | 948 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 6424 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 930 | 0.080 |
Why?
|
| United States | 2 | 2025 | 12002 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3812 | 0.060 |
Why?
|
| Adult | 5 | 2025 | 31114 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3123 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 33726 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3367 | 0.040 |
Why?
|
| Choroid Diseases | 1 | 2019 | 17 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1413 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 303 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 4058 | 0.040 |
Why?
|
| Papilledema | 1 | 2019 | 80 | 0.030 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 41 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 148 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2019 | 191 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 370 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 313 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 587 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 52 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 20889 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 107 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 612 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2822 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3338 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2063 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6175 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6771 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 10037 | 0.010 |
Why?
|